Ticker Details
Kiniksa Pharmaceuticals, Ltd.
IPO Date:	May 21, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.18B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 2.91%
Avg Daily Range (30 D):	$1.92 | 2.81%
Avg Daily Range (90 D):	$1.62 | 2.79%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.55M
Avg Daily Volume (90 D):	.58M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	2,033
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$3.13M
Avg Institutional Trade (90 D):	$4.22M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.25M
Avg Closing Trade (30 D):	$5.03M
Avg Closing Trade (90 D):	$7.63M
Avg Closing Volume:	86.68K

News

Jul 28, 2026 @ 11:30 AM Kiniksa Pharmaceuticals Reports Second Quarter 202... Source: Na

Apr 28, 2026 @ 11:10 PM Why Kiniksa Pharmaceuticals International Stock Ra... Source: Eric Volkman

Oct 17, 2025 @ 12:00 PM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug... Source: Kiniksa Pharmaceuticals International

Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A

May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.07	$.33	$.3
Diluted EPS	$.98	$.3	$.27
Revenue	$840.85M	$243.6M	$214.27M
Gross Profit	$755.28M	$220.03M	$193.47M
Net Income / Loss	$80.66M	$25.43M	$22.59M
Operating Income / Loss	$100.25M	$27.19M	$29.27M
Cost of Revenue	$85.57M	$23.57M	$20.8M
Net Cash Flow	$-16.36M	$-14.28M	$24.36M
PE Ratio